PRELUDE THERAPEUTICS

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 20 Aug 2020

Owner Info

Prelude Therapeutics Incorporated

200 Powder Mill Road,

Experimental Station E400/3213, UNITED STATES OF AMERICA

Serial Number

2076639 filed on 21 Nov 2019

Correspondent

Lisa Bollinger Gehman Baker & Hostetler LLP

2929 Arch Street,,

Cira Centre, 12th Floor,

UNITED STATES OF AMERICA

PRELUDE THERAPEUTICS

Classification Information

2076639

21 Nov 2019

21 Nov 2029

WORD

31 May 2019

Status Date	Action Taken
20^th Aug 2020	International Registration in Australia Protected correspondence sent
19^th Aug 2020	IP Right Registration Published
19^th Aug 2020	Status change to Registered/Protected
13^th Jun 2020	Application Accepted correspondence sent
12^th Jun 2020	IP Right has been Examined
12^th Jun 2020	IP Right Acceptance Published
12^th Jun 2020	Status change to Accepted
19^th Mar 2020	Awaiting examination
19^th Mar 2020	Examination expedited
19^th Mar 2020	IP Right Filed Published